Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions
- PMID: 20199857
- PMCID: PMC2890041
- DOI: 10.1016/j.rmed.2009.10.030
Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions
Abstract
Background: Among older persons, we previously endorsed a two-step spirometric definition of chronic obstructive pulmonary disease (COPD) that requires a ratio of forced expiratory volume in 1sec to forced vital capacity (FEV(1)/FVC) below .70, and an FEV(1) below the 5th or 10th standardized residual percentile ("SR-tile strategy").
Objective: To evaluate the clinical validity of an SR-tile strategy, compared to a current definition of COPD, as published by the Global Initiative for Obstructive Lung Disease (GOLD-COPD), in older persons.
Methods: We assessed national data from 2480 persons aged 65-80 years. In separate analyses, we evaluated the association of an SR-tile strategy with mortality and respiratory symptoms, relative to GOLD-COPD. As per convention, GOLD-COPD was defined solely by an FEV(1)/FVC<.70, with severity staged according to FEV(1) cut-points at 80 and 50 percent predicted (%Pred).
Results: Among 831 participants with GOLD-COPD, the risk of death was elevated only in 179 (21.5%) of those who also had an FEV(1)<5th SR-tile; and the odds of having respiratory symptoms were elevated only in 310 (37.4%) of those who also had an FEV(1)<10th SR-tile. In contrast, GOLD-COPD staged at an FEV(1) 50-79%Pred led to misclassification (overestimation) in terms of 209 (66.4%) and 77 (24.6%) participants, respectively, not having an increased risk of death or likelihood of respiratory symptoms.
Conclusion: Relative to an SR-tile strategy, the majority of older persons with GOLD-COPD had neither an increased risk of death nor an increased likelihood of respiratory symptoms. These results raise concerns about the clinical validity of GOLD guidelines in older persons.
Published by Elsevier Ltd.
Conflict of interest statement
Similar articles
-
Defining chronic obstructive pulmonary disease in older persons.Respir Med. 2009 Oct;103(10):1468-76. doi: 10.1016/j.rmed.2009.04.019. Epub 2009 May 21. Respir Med. 2009. PMID: 19464159 Free PMC article.
-
Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.Eur Respir J. 2006 Feb;27(2):378-83. doi: 10.1183/09031936.06.00036005. Eur Respir J. 2006. PMID: 16452596
-
Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?Respir Med. 2007 Jun;101(6):1097-105. doi: 10.1016/j.rmed.2006.11.019. Epub 2007 Jan 18. Respir Med. 2007. PMID: 17239575
-
What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?Drugs Aging. 2008;25(9):717-28. doi: 10.2165/00002512-200825090-00001. Drugs Aging. 2008. PMID: 18729545 Review.
-
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2020 May 1;5(5):CD002309. doi: 10.1002/14651858.CD002309.pub6. Cochrane Database Syst Rev. 2020. PMID: 32356609 Free PMC article.
Cited by
-
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.Thorax. 2014 May;69(5):409-14. doi: 10.1136/thoraxjnl-2012-202810. Epub 2013 Mar 23. Thorax. 2014. PMID: 23525095 Free PMC article.
-
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Lung India. 2013 Jul;30(3):228-67. doi: 10.4103/0970-2113.116248. Lung India. 2013. PMID: 24049265 Free PMC article.
-
Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.J Gerontol A Biol Sci Med Sci. 2012 Mar;67(3):264-75. doi: 10.1093/gerona/glr198. Epub 2011 Dec 1. J Gerontol A Biol Sci Med Sci. 2012. PMID: 22138206 Free PMC article.
-
Association of Symptoms of Obstructive Lung Disease and All-Cause Mortality in Older Adult Smokers.J Am Geriatr Soc. 2019 Oct;67(10):2116-2122. doi: 10.1111/jgs.16052. Epub 2019 Jun 27. J Am Geriatr Soc. 2019. PMID: 31250432 Free PMC article.
-
GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population.ERJ Open Res. 2016 Oct 19;2(4):00084-2015. doi: 10.1183/23120541.00084-2015. eCollection 2016 Oct. ERJ Open Res. 2016. PMID: 28053971 Free PMC article.
References
-
- GOLD executive summary. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:532–55. - PubMed
-
- Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68. - PubMed
-
- Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2007;147:633–8. - PubMed
-
- Mannino DM, Doherty DE, Buist AS. Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: findings from the atherosclerotic risk in communities (ARIC) study. Respir Med. 2006;100:115–22. - PubMed
-
- Hansen JF, Sun XG, Wasserman K. Spirometric criteria for airway obstruction. Chest. 2007;131:349–55. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials